Vimab Group AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 67.45 million compared to SEK 39.77 million a year ago. Revenue was SEK 68.49 million compared to SEK 43 million a year ago.

Net loss was SEK 17.95 million compared to SEK 10.45 million a year ago. Basic loss per share from continuing operations was SEK 0.8 compared to SEK 0.5 a year ago.